Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
60
datasets available to search
ShareScore release 0.7.1
Dataset results
60 results for “PLD”
Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD)
ClinicalTrials.gov study NCT03949634. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy
ClinicalTrials.gov study NCT02953184. IPD Sharing: YES. Countries: 1. Publications: 6.
PLD-cyclophosphamide-Nab-P Continuously Combined With Dual HER2 Blockage for HER2-positive Breast Cancer
ClinicalTrials.gov study NCT05346107. IPD Sharing: NO. Countries: 1. Publications: 1.
Real-World Effectiveness of PLD in Platinum- Sensitive Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT03562533. IPD Sharing: NO. Countries: 1. Publications: 1.
Oregovomab and PLD in PARP Inhibitor Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment
ClinicalTrials.gov study NCT05407584. IPD Sharing: NO. Countries: 1. Publications: 1.
Comparative Phylogeography of Three Marine Species with Different PLD Modes Reveals Two Genetic Breaks Across the Southern Caribbean Sea
<p><strong>Supplementary Materials: </strong><strong>Figure S1. </strong>Bar graphs of the population ancestry coefficient from the STRUCTURE program indicating the probable number of populations (<em>K </em>= 2 - 6) for each species: (<strong>a</strong>) <em>Acanthemblemaria rivasi</em>, (<strong>b</strong>) <em>Cittarium pica</em>, and (<strong>c</strong>) <em>Nerita tessellata</em>; <strong>Figure S2.</strong>Correlogram plots of correlation coefficients and averages of estimated <em>Ф</em><sub>ST</sub> at each linear geographic distance class mark (right) for (<strong>a</strong>) <em>Acanthemblemaria rivasi</em>, (<strong>b</strong>) <em>Cittarium pica</em>, and (<strong>c</strong>) <em>Nerita tessellata</em>; <strong>Figure S3.</strong> Dendrograms of <em>Ф</em><sub>ST </sub>values constructed with the UPGMA method for <em>A. rivasi</em>,<em> C. pica</em>, and <em>N. tessellata</em> and spatial autocorrelation analysis between the <em>Ф</em><sub>ST</sub> matrices relating the localities across the southern and southwestern Caribbean, Colombia sector. (<strong>a</strong>) Analysis between <em>A. rivasi</em> and <em>C. pica</em>; (<strong>b</strong>) <em>A. rivasi</em> and <em>N. tessellata</em>; (<strong>c</strong>) <em>C. pica</em> and <em>N. tessellata</em>. <em>FC </em>= topological concordance factor; <em>W </em>= Kendall's statistic for topological (<em>W</em>t) and genetic (<em>W</em>g) congruence; <em>rm </em>= Mantel correlation coefficient; <em>p </em>= significance level. The black, blue, and red colors of the site names indicate high, medium, and low concordance among their locations in the dendrograms; <strong>Table S1</strong>. The genetic diversity indices calculated for <em>Acanthemblemaria rivasi</em>, <em>Cittarium pica</em>, and <em>Nerita tessellata</em> in five localities distributed across the southern Caribbean Sea, Colombia sector. Num: number of alleles, Eff_num: effective number of alleles, <em>H</em>o: observed heterozygosity, <em>H</em>s: heterozygosity within populations, and <em>G</em>is: inbreeding coefficient.</p>
Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov study NCT05261490. IPD Sharing: YES. Countries: 1. Publications: 0.
Non-interventional European Study of Trabectedin + PLD in the Treatment of Relapsed Ovarian Cancer (ROC) Patients
ClinicalTrials.gov study NCT02825420. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Dose Escalation Study of BIBF 1120 in Combination With Carboplatin and PLD in Relapsed Ovarian Cancer (OC)
ClinicalTrials.gov study NCT01329549. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT01314105. IPD Sharing: NO. Countries: 1. Publications: 0.
A Multicenter, International, Prospective and Retrospective, Follow-up Registry to Monitor the Efficacy and Safety of the Occlutech Paravalvular Leak Device (PLD) in Patients With Mitral or Aortic Par
ClinicalTrials.gov study NCT07037446. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Observational Study of YONDELIS®+PLD for the Treatment of Patients With Platinum-sensitive Relapse of Ovarian Cancer
ClinicalTrials.gov study NCT01869400. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Sintilimab and Bevacizumab Biosimilar Combined With PLD in mTNBC
ClinicalTrials.gov study NCT05386524. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effectiveness and Safety of XELOX and Tislelizumab + PLD for Resectable Gastric Cancer (LidingStudy)
ClinicalTrials.gov study NCT05536102. IPD Sharing: NO. Countries: 1. Publications: 0.
APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST
ClinicalTrials.gov study NCT06687070. IPD Sharing: Not stated. Countries: 1. Publications: 0.
IN10018 in Combination With Pegylated Liposomal Doxorubicin (PLD) vs. Placebo in Combination With PLD for the Treatment of Platinum-resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT06014528. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PLD Combined With Cisplatin in the Treatment of Advanced Poorly Differentiated Thyroid Carcinoma
ClinicalTrials.gov study NCT03387943. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Development and Assessment of The Polycystic Liver Disease Questionnaire (PLD-Q).
ClinicalTrials.gov study NCT02173080. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1)
ClinicalTrials.gov study NCT07109414. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer
ClinicalTrials.gov study NCT00982631. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.